Inventor
MARK TODTENKOPF
Inventor
US
Overview
Patents· 5 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Kprimary
A61KPreparations for medical, dental or toiletry purposes33%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations33%
C07DHeterocyclic compounds33%
PatentTitleYear
12,194,035Methods for treating antipsychotic-induced weight gain202511,793,805Methods for treating antipsychotic-induced weight gain202311,351,166Methods for treating antipsychotic-induced weight gain202211,241,425Composition for treating mental illness202211,185,541Methods for treating antipsychotic-induced weight gain2021Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2021–2025Patents assigned to ALKERMES PHARMA IRELAND LTD (5)· patent assignee history
2021–2025Based in US· patent location history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| ALKERMES PHARMA IRELAND LTD | 5 | 2021–2025 |
Locations
| Location | Patents | Span |
|---|---|---|
| US | 5 | 2021–2025 |